Navigation Links
3SBio Inc. Announces Second Quarter 2008 Results
Date:8/12/2008

Property, plant and equipment, net 49,465 59,386 8,658

Lease prepayments 9,247 9,070 1,322

License fee -- 6,287 917

Non-current deposits 6,124 9,258 1,350

Income tax receivable 556 -- --

Deferred tax assets 1,857 1,724 251

Total assets 973,475 977,588 142,524

Liabilities

Current liabilities

Accounts payable 1,693 2,971 433

Deferred grant income 374 374 55

Accrued expenses and other payables 22,626 30,967 4,515

Income tax payable -- 4,638 676

Other current liabilities 67 71 10

Total current liabilities 24,760 39,021 5,689

Deferred grant income 3,526 3,339 487

Other liabilities 848 810 118

Total liabilities 29,134 43,170 6,294

Commitments and contingencies

Minority interests 549 454 66

Shareholders' equity

Share capital - ordinary shares US$0.0001

par value, 500,000,000

shares authorized, 152,099,155 shares

issued and outstanding as of

December 31, 2007 and June 30, 2008 122 122 18

Additional paid-in capital 917,527 919,968 134,124

Accumulated other comprehensive loss (48,338) (99,742) (14,542)

Retained earnings 74,481 113,616 16,564

Total shareholders' equity 943,792 933,96
'/>"/>

SOURCE 3SBio Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
2. 3SBio Inc. to Hold Annual General Meeting
3. 3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007
4. 3SBio Inc. To Present at the 19th Annual Piper Jaffray Health Care Conference
5. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
6. 3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. 3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
8. 3SBio Inc. Announces Change to the Board of Directors
9. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
10. 3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer
11. 3SBio Inc. Approves Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... regulated information -- UCB today announced an important advance ... topline results from the latest Phase 3 study ... evaluate the efficacy and safety of brivaracetam ... to placebo, as adjunctive treatment in adult focal ... despite treatment with one or two concomitant antiepileptic ...
(Date:7/23/2014)... California (PRWEB) July 23, 2014 With the ... in HD resolution for more than 15 minutes, Fastec Imaging ... the world of high speed imaging. “Finally, a high speed ... camera we use in our everyday lives.” proclaims Matt Kearney, ... Fastec has always been to demystify and simplify the traditionally ...
(Date:7/22/2014)... (PR Web) July 21, 2014 (PRWEB) July 23, ... for Biomaterials, at Rutgers University. , The ... and ideas across the full spectrum of scientists ... selected research and development topics that represent the ... have been programmed to:,     Provide ...
(Date:7/22/2014)... Terry Baughn, a senior lecturer in mechanical engineering at ... Engineer of the Year by the North Texas section ... ASME has more than 130,000 members in 158 countries ... technology to assist the engineering community, benefiting the world. ... Texas Society of Professional Engineers honors banquet. Baughn retired ...
Breaking Biology Technology:Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Fastec Imaging Introduces the First High Speed Camcorder 2Fastec Imaging Introduces the First High Speed Camcorder 3The 2014 NJ Symposium on Biomaterials Science Earns Society for Biomaterials Endorsement 2UT Dallas professor receives Engineer of the Year award 2
... YORK, Dec. 10, 2010 Ramius V&O Acquisition LLC, ... that it has sent a letter to the Board ... CYPB ) outlining its willingness to acquire all of ... $5.50 per share.  The offer is conditioned upon Cypress ...
... will help UK athletes reach the top of their ... the UK,s high performance sports agency, has reached an ... edge technology developed by Argento Diagnostics to improve training ... to monitor various proteins which reveal details about the ...
... ALBUQUERQUE, N.M. A benchtop version of the world,s ... seven-thousandth the thickness of a human hair has been ... researcher Jianyu Huang. To better study the anode,s ... a transmission electron microscope (TEM) at the Center for ...
Cached Biology Technology:Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience for $5.50 Per Share 2Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience for $5.50 Per Share 3Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience for $5.50 Per Share 4Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience for $5.50 Per Share 5Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience for $5.50 Per Share 6Medical science helps UK athletes reach peak performance 2Medical science helps UK athletes reach peak performance 3World's smallest battery created at CINT nanotechnology center 2World's smallest battery created at CINT nanotechnology center 3
(Date:7/22/2014)... scientific discovery showed that mutations in prickle genes ... disorder characterized by repeated seizures over time. However, ... unknown. , A new University of Iowa study, ... of the National Academy of Sciences , reveals ... UI researchers have identified the basic cellular mechanism ...
(Date:7/22/2014)... thawing might not be good for the average steak, ... as they prepare to survive Alaska,s winter cold. , ... outside than a steak does in your freezer and ... in better shape than the steak," said Don Larson, ... on a recent paper demonstrating that freeze tolerance in ...
(Date:7/22/2014)... new study that examined the survival rates of ... in commercial longline fishing operations found large differences ... thresher, dusky, and scalloped hammerhead being the most,vulnerable. ... of Miami (UM) Rosenstiel School of,Marine and Atmospheric ... and Policy, provides,new information to consider for future ...
Breaking Biology News(10 mins):UI study finds potential genetic link between epilepsy and neurodegenerative disorders 2Alaska frogs reach record lows in extreme temperature survival 2Alaska frogs reach record lows in extreme temperature survival 3New study reveals vulnerability of sharks as collateral damage in commercial fishing 2
... in Ireland are mislabelled, as compared to 7% in the ... Fish and Fisheries . This is the first ... sold in Ireland and the UK. Both countries operate under ... Using a DNA barcoding technique (COI barcoding gene), scientists ...
... of the treats of summerfresh, antioxidant-rich blueberrieshas new competition for ... contenders are keeping the title in the family. , Researchers ... the tropical regions of Central and South Americathe New World ... the blueberries sold in U.S. markets. , This finding is ...
... patient has been enrolled by researchers at The University of ... first double-blind clinical trial studying the safety and efficacy of ... to 19 days after an ischemic stroke. The Phase ... regenerative therapy developed by Aldagen that uses a patient,s own ...
Cached Biology News:Cod mislabeling 4 times more prevalent in Ireland than UK, study shows 2Summer's superfruit challenged: Latin American blueberries found to be 'extreme superfruits' 2Study uses new stem cell therapy in patients up to 19 days after stroke 2
Rat integrin a6b1, mainly associated with epithelial cells. Does not react with rat fibroblasts....
Rabbit polyclonal to MDM2 (phospho S185) ( Abpromise for all tested applications). entrezGeneID: 4193 SwissProtID: Q00987...
Anti-ADAM-12 (Meltrin Alpha); carboxy terminal end; rabbit host...
Chaps Cell Extract Buffer can be used to lyse cells under nondenaturing conditions and is recommendedfor the preparation of cell lysates to be used with our caspase signaling pathway antibodies...
Biology Products: